These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 9735160

  • 1. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
    Cooper GR, Barr A, Wolff DJ.
    Arch Biochem Biophys; 1998 Sep 15; 357(2):195-206. PubMed ID: 9735160
    [Abstract] [Full Text] [Related]

  • 2. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
    Cooper GR, Mialkowski K, Wolff DJ.
    Arch Biochem Biophys; 2000 Mar 01; 375(1):183-94. PubMed ID: 10683266
    [Abstract] [Full Text] [Related]

  • 3. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase.
    Wolff DJ, Lubeskie A.
    Arch Biochem Biophys; 1995 Jan 10; 316(1):290-301. PubMed ID: 7530937
    [Abstract] [Full Text] [Related]

  • 4. Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine.
    Wolff DJ, Lubeskie A.
    Arch Biochem Biophys; 1996 Jan 15; 325(2):227-34. PubMed ID: 8561501
    [Abstract] [Full Text] [Related]

  • 5. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
    Bryk R, Lubeskie A, Wolff DJ.
    Arch Biochem Biophys; 1999 Sep 15; 369(2):243-51. PubMed ID: 10486143
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of nitric oxide synthase isoforms by tris-malonyl-C(60)-fullerene adducts.
    Wolff DJ, Papoiu AD, Mialkowski K, Richardson CF, Schuster DI, Wilson SR.
    Arch Biochem Biophys; 2000 Jun 15; 378(2):216-23. PubMed ID: 10860539
    [Abstract] [Full Text] [Related]

  • 7. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.
    Wolff DJ, Lubeskie A, Gauld DS, Neulander MJ.
    Eur J Pharmacol; 1998 Jun 05; 350(2-3):325-34. PubMed ID: 9696424
    [Abstract] [Full Text] [Related]

  • 8. Neuronal nitric oxide synthase modulates basal catecholamine secretion in bovine chromaffin cells.
    Vicente S, González MP, Oset-Gasque MJ.
    J Neurosci Res; 2002 Aug 01; 69(3):327-40. PubMed ID: 12125074
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas.
    Wolff DJ, Gauld DS, Neulander MJ, Southan G.
    J Pharmacol Exp Ther; 1997 Oct 01; 283(1):265-73. PubMed ID: 9336332
    [Abstract] [Full Text] [Related]

  • 10. Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cells treated with "irreversible" NO synthase inhibitors.
    Wolff DJ, Lubeskie A, Li C.
    Arch Biochem Biophys; 1997 Feb 01; 338(1):73-82. PubMed ID: 9015390
    [Abstract] [Full Text] [Related]

  • 11. Neuronal nitric oxide synthase (NNOS) catalyzes one-electron reduction of 2,4,6-trinitrotoluene, resulting in decreased nitric oxide production and increased nNOS gene expression: implication for oxidative stress.
    Kumagai Y, Kikushima M, Nakai Y, Shimojo N, Kunimoto M.
    Free Radic Biol Med; 2004 Aug 01; 37(3):350-7. PubMed ID: 15223068
    [Abstract] [Full Text] [Related]

  • 12. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
    Reif DW, McCreedy SA.
    Arch Biochem Biophys; 1995 Jun 20; 320(1):170-6. PubMed ID: 7540822
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of nitric oxide synthase isoforms by porphyrins.
    Wolff DJ, Naddelman RA, Lubeskie A, Saks DA.
    Arch Biochem Biophys; 1996 Sep 01; 333(1):27-34. PubMed ID: 8806750
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
    Bryk R, Wolff DJ.
    Biochemistry; 1998 Apr 07; 37(14):4844-52. PubMed ID: 9538001
    [Abstract] [Full Text] [Related]

  • 17. Distinct roles of nitric oxide synthases and interstitial cells of Cajal in rectoanal relaxation.
    Terauchi A, Kobayashi D, Mashimo H.
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug 07; 289(2):G291-9. PubMed ID: 15845873
    [Abstract] [Full Text] [Related]

  • 18. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
    Grant SK, Green BG, Stiffey-Wilusz J, Durette PL, Shah SK, Kozarich JW.
    Biochemistry; 1998 Mar 24; 37(12):4174-80. PubMed ID: 9521739
    [Abstract] [Full Text] [Related]

  • 19. Thiols and neuronal nitric oxide synthase: complex formation, competitive inhibition, and enzyme stabilization.
    Gorren AC, Schrammel A, Schmidt K, Mayer B.
    Biochemistry; 1997 Apr 08; 36(14):4360-6. PubMed ID: 9100033
    [Abstract] [Full Text] [Related]

  • 20. Interferon-gamma-inducible murine macrophage nitric oxide synthase: studies on the mechanism of inhibition by imidazole agents.
    Wolff DJ, Gribin BJ.
    Arch Biochem Biophys; 1994 Jun 08; 311(2):293-9. PubMed ID: 7515612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.